Growth Metrics

MeiraGTx Holdings (MGTX) Capital Expenditures (2017 - 2025)

MeiraGTx Holdings posted quarterly Capital Expenditures of $272000.0 for Q4 2025, down 77.67% year-on-year from $1.2 million in Q4 2024, and down 55.41% on a QoQ basis from $610000.0 in Q3 2025.

MeiraGTx Holdings (MGTX) has 9 years of Capital Expenditures data on file, last reported at $272000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 77.67% year-over-year to $272000.0; the trailing twelve-month figure through Dec 2025 stood at $3.8 million (down 22.79% YoY), and the FY2025 full-year result was $3.8 million, down 22.79% from the prior year.
  • Capital Expenditures for Q4 2025 stood at $272000.0, down from $610000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $24.4 million in Q4 2021 and bottomed at $272000.0 in Q4 2025.
  • The 5-year median for Capital Expenditures is $4.0 million (2021), against an average of $6.0 million.
  • The widest annual swing landed in 2021, when Capital Expenditures jumped 204.04%; it then tumbled 80.5% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $24.4 million in 2021, then plunged by 65.15% to $8.5 million in 2022, then slumped by 64.32% to $3.0 million in 2023, then tumbled by 59.8% to $1.2 million in 2024, then tumbled by 77.67% to $272000.0 in 2025.
  • The last three Capital Expenditures figures came in at $272000.0 (Q4 2025), $610000.0 (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 133.40 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 230.60 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 21.83 Mn
10 MeiraGTx Holdings 856.58 Mn 790.65 Mn 74.89 Mn 272,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 272,000.00
Dec 31, 2025 272,000.00
Sep 30, 2025 610,000.00
Sep 30, 2025 610,000.00
Jun 30, 2025 1.23 Mn
Jun 30, 2025 1.23 Mn
Mar 31, 2025 1.71 Mn
Mar 31, 2025 1.71 Mn
Dec 31, 2024 1.22 Mn
Dec 31, 2024 1.22 Mn
Sep 30, 2024 730,000.00
Sep 30, 2024 730,000.00
Jun 30, 2024 1.33 Mn
Jun 30, 2024 1.33 Mn
Mar 31, 2024 1.68 Mn
Mar 31, 2024 1.68 Mn
Dec 31, 2023 3.03 Mn
Dec 31, 2023 3.03 Mn
Sep 30, 2023 3.56 Mn
Sep 30, 2023 3.56 Mn
Jun 30, 2023 4.98 Mn
Jun 30, 2023 4.98 Mn
Mar 31, 2023 8.61 Mn
Mar 31, 2023 8.61 Mn
Dec 31, 2022 8.49 Mn
Dec 31, 2022 8.49 Mn
Sep 30, 2022 10.01 Mn
Sep 30, 2022 10.01 Mn
Jun 30, 2022 14.00 Mn
Jun 30, 2022 14.00 Mn
Mar 31, 2022 12.46 Mn
Mar 31, 2022 12.46 Mn
Dec 31, 2021 24.37 Mn
Dec 31, 2021 24.37 Mn
Sep 30, 2021 11.91 Mn
Sep 30, 2021 11.91 Mn
Jun 30, 2021 5.58 Mn
Jun 30, 2021 5.58 Mn
Mar 31, 2021 4.50 Mn
Mar 31, 2021 4.50 Mn
Dec 31, 2020 8.02 Mn
Dec 31, 2020 8.02 Mn
Sep 30, 2020 5.96 Mn
Sep 30, 2020 5.96 Mn
Jun 30, 2020 2.92 Mn
Jun 30, 2020 2.92 Mn
Mar 31, 2020 4.04 Mn
Mar 31, 2020 4.04 Mn
Dec 31, 2019 4.75 Mn
Dec 31, 2019 4.75 Mn
Sep 30, 2019 2.02 Mn
Sep 30, 2019 2.02 Mn
Jun 30, 2019 1.09 Mn
Jun 30, 2019 1.09 Mn
Mar 31, 2019 1.12 Mn
Mar 31, 2019 1.12 Mn
Dec 31, 2018 8.89 Mn
Dec 31, 2018 8.89 Mn
Sep 30, 2018 1.05 Mn
Sep 30, 2018 1.05 Mn
Jun 30, 2018 107,564.00
Jun 30, 2018 107,564.00
Mar 31, 2018 1.21 Mn
Mar 31, 2018 1.21 Mn
Dec 31, 2017 2.15 Mn
Dec 31, 2017 2.15 Mn
Sep 30, 2017 3.56 Mn
Sep 30, 2017 3.56 Mn